Enovis Corporation is a medical technology company dedicated to developing clinically differentiated solutions through the manufacturing and distribution of medical devices for reconstructive surgery, rehabilitation, pain management, and physical therapy. It operates in two segments: Prevention & Recovery, which offers rigid bracing products, orthopedic soft goods, vascular systems, compression garments, and recovery sciences products like bone growth and electrical stimulators; and Reconstructive, which focuses on knee, hip, shoulder, elbow, foot, ankle, and finger implants, along with surgical tools and minimally invasive surgery solutions through Novastep. The ENOV YTD return is shown above.
The YTD Return on the ENOV YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether ENOV YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ENOV YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|